Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of SCARB1 mRNA | affects expression | 21346803
|
C076996 |
27-hydroxycholesterol |
27-hydroxycholesterol results in decreased expression of SCARB1 protein | decreases expression | 14614521
|
C076996 |
27-hydroxycholesterol |
27-hydroxycholesterol results in increased expression of SCARB1 protein | increases expression | 14614521
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of SCARB1 protein | affects expression | 20106945
|
C103303 |
alitretinoin |
alitretinoin results in increased expression of SCARB1 mRNA | increases expression | 16142410
|
D000537 |
Aluminum Oxide |
Aluminum Oxide results in decreased expression of SCARB1 mRNA | decreases expression | 19464052
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of SCARB1 mRNA | affects expression | 16483693
|
D001241 |
Aspirin |
Aspirin affects the expression of SCARB1 mRNA | affects expression | 16816107
|
D001241 |
Aspirin |
[Aspirin co-treated with Fenofibrate] results in increased expression of SCARB1 protein | affects cotreatment|increases expression | 16816107
|
D001241 |
Aspirin |
Aspirin results in decreased expression of and results in decreased activity of SCARB1 protein | decreases activity|decreases expression | 16816107
|
D001241 |
Aspirin |
Aspirin results in increased expression of and results in increased activity of SCARB1 protein | increases activity|increases expression | 16816107
|
D001241 |
Aspirin |
Aspirin affects the expression of SCARB1 protein | affects expression | 16816107
|
D019207 |
beta Carotene |
SCARB1 protein results in increased transport of beta Carotene | increases transport | 16177187
|
C006780 |
bisphenol A |
bisphenol A results in decreased expression of SCARB1 mRNA | decreases expression | 15901920
|
D002784 |
Cholesterol |
SCARB1 protein affects the transport of Cholesterol | affects transport | 15883047
|
D002791 |
Cholesterol, Dietary |
[Fructose co-treated with Dietary Fats co-treated with Cholesterol, Dietary] results in increased expression of SCARB1 mRNA | affects cotreatment|increases expression | 19509184
|
D008076 |
Cholesterol, HDL |
Fenofibrate inhibits the reaction [SCARB1 protein results in increased export of Cholesterol, HDL] | decreases reaction|increases export | 17533223
|
D008076 |
Cholesterol, HDL |
SCARB1 protein results in increased export of Cholesterol, HDL | increases export | 17533223
|
D008076 |
Cholesterol, HDL |
SDZ HDL 376 analog inhibits the reaction [SCARB1 protein results in increased export of Cholesterol, HDL] | decreases reaction|increases export | 17533223
|
D008076 |
Cholesterol, HDL |
SDZ HDL 376 inhibits the reaction [SCARB1 protein results in increased export of Cholesterol, HDL] | decreases reaction|increases export | 17533223
|
C023511 |
cholesteryl oleyl ether |
Fenofibrate inhibits the reaction [SCARB1 protein results in increased uptake of cholesteryl oleyl ether] | decreases reaction|increases uptake | 17533223
|
C023511 |
cholesteryl oleyl ether |
SCARB1 protein results in increased uptake of cholesteryl oleyl ether | increases uptake | 17533223
|
C023511 |
cholesteryl oleyl ether |
SDZ HDL 376 analog inhibits the reaction [SCARB1 protein results in increased uptake of cholesteryl oleyl ether] | decreases reaction|increases uptake | 17533223
|
C023511 |
cholesteryl oleyl ether |
SDZ HDL 376 inhibits the reaction [SCARB1 protein results in increased uptake of cholesteryl oleyl ether] | decreases reaction|increases uptake | 17533223
|
D002995 |
Clofibric Acid |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of SCARB1 mRNA | affects cotreatment|affects expression | 17602206
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of SCARB1 mRNA | decreases expression | 20106945
|
D003907 |
Dexamethasone |
Dexamethasone results in decreased expression of SCARB1 protein | decreases expression | 12475377
|
D003993 |
Dibutyl Phthalate |
Dibutyl Phthalate results in decreased expression of SCARB1 mRNA | decreases expression | 14617579 15141095 15987825
|
D003993 |
Dibutyl Phthalate |
Dibutyl Phthalate results in decreased expression of SCARB1 protein | decreases expression | 14617579 15141095
|
D004041 |
Dietary Fats |
[Fructose co-treated with Dietary Fats co-treated with Cholesterol, Dietary] results in increased expression of SCARB1 mRNA | affects cotreatment|increases expression | 19509184
|
D004041 |
Dietary Fats |
Dietary Fats results in decreased expression of SCARB1 mRNA | decreases expression | 18457598
|
D004051 |
Diethylhexyl Phthalate |
Diethylhexyl Phthalate results in decreased expression of SCARB1 mRNA | decreases expression | 16690193
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of SCARB1 mRNA | affects cotreatment|affects expression | 17602206
|
D004391 |
Dust |
Dust results in decreased expression of SCARB1 mRNA | decreases expression | 17805423
|
D004958 |
Estradiol |
Estradiol results in decreased expression of SCARB1 protein | decreases expression | 17673517
|
D000431 |
Ethanol |
Ethanol results in increased expression of SCARB1 mRNA | increases expression | 15353170
|
D004997 |
Ethinyl Estradiol |
ESR1 protein promotes the reaction [Ethinyl Estradiol results in decreased expression of SCARB1 protein modified form] | decreases expression|increases reaction | 17673517
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol affects the expression of TRA2B protein] which affects the splicing of SCARB1 mRNA | affects expression|affects splicing | 17673517
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the splicing of SCARB1 mRNA | affects splicing | 17673517
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol affects the expression of TRA2B protein] which affects the splicing of SCARB1 mRNA | affects expression|affects splicing | 17673517
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the splicing of SCARB1 mRNA | affects splicing | 17673517
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of SCARB1 mRNA | decreases expression | 15834898 12475377 15901920
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of SCARB1 protein | decreases expression | 12475377 17673517
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of SCARB1 protein | increases expression | 12475377
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of SCARB1 protein modified form | increases expression | 17673517
|
C108606 |
ezetimibe |
ezetimibe results in decreased expression of SCARB1 mRNA | decreases expression | 16177187
|
D011345 |
Fenofibrate |
[Aspirin co-treated with Fenofibrate] results in increased expression of SCARB1 protein | affects cotreatment|increases expression | 16816107
|
D011345 |
Fenofibrate |
Fenofibrate results in increased expression of SCARB1 protein | increases expression | 16816107
|
D011345 |
Fenofibrate |
Fenofibrate inhibits the reaction [SCARB1 protein results in increased export of Cholesterol, HDL] | decreases reaction|increases export | 17533223
|
D011345 |
Fenofibrate |
Fenofibrate inhibits the reaction [SCARB1 protein results in increased uptake of cholesteryl oleyl ether] | decreases reaction|increases uptake | 17533223
|
D011345 |
Fenofibrate |
Fenofibrate results in decreased activity of SCARB1 protein | decreases activity | 17533223
|
D005419 |
Flavonoids |
Flavonoids results in increased expression of SCARB1 mRNA | increases expression | 18035473
|
D005632 |
Fructose |
[Fructose co-treated with Dietary Fats co-treated with Cholesterol, Dietary] results in increased expression of SCARB1 mRNA | affects cotreatment|increases expression | 19509184
|
D005632 |
Fructose |
Fructose results in decreased expression of SCARB1 mRNA | decreases expression | 19193814
|
C059714 |
HDL cholesteryl ester |
SCARB1 protein results in increased transport of HDL cholesteryl ester | increases transport | 16816107
|
C440499 |
lipopolysaccharide, Escherichia coli 0111 B4 |
lipopolysaccharide, Escherichia coli 0111 B4 results in decreased expression of SCARB1 mRNA | decreases expression | 12010990
|
C440499 |
lipopolysaccharide, Escherichia coli 0111 B4 |
lipopolysaccharide, Escherichia coli 0111 B4 results in decreased expression of SCARB1 protein | decreases expression | 12010990
|
C440499 |
lipopolysaccharide, Escherichia coli 0111 B4 |
Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in decreased expression of SCARB1 mRNA] | decreases expression|decreases reaction | 12010990
|
D008095 |
Lithocholic Acid |
Lithocholic Acid results in decreased expression of SCARB1 mRNA | decreases expression | 15883047
|
D008095 |
Lithocholic Acid |
Lithocholic Acid results in decreased expression of SCARB1 protein | decreases expression | 15883047
|
C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid results in decreased expression of SCARB1 mRNA | decreases expression | 17681415
|
D010634 |
Phenobarbital |
Phenobarbital affects the expression of SCARB1 mRNA | affects expression | 19136022
|
D010672 |
Phenytoin |
Phenytoin results in decreased expression of SCARB1 mRNA | decreases expression | 15136057
|
D010795 |
Phthalic Acids |
Phthalic Acids results in decreased expression of SCARB1 mRNA | decreases expression | 15728792
|
C006253 |
pirinixic acid |
pirinixic acid affects the expression of SCARB1 mRNA | affects expression | 19136022
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of SCARB1 mRNA | increases expression | 17426115 16985257
|
D011285 |
Pregnenolone Carbonitrile |
Pregnenolone Carbonitrile results in decreased expression of SCARB1 mRNA | decreases expression | 15883047
|
D011285 |
Pregnenolone Carbonitrile |
Pregnenolone Carbonitrile results in decreased expression of SCARB1 protein | decreases expression | 15883047
|
C014794 |
retinol palmitate |
retinol palmitate results in increased expression of SCARB1 mRNA | increases expression | 17299104
|
D012293 |
Rifampin |
Rifampin results in decreased expression of SCARB1 mRNA | decreases expression | 15883047
|
D012293 |
Rifampin |
Rifampin results in decreased expression of SCARB1 protein | decreases expression | 15883047
|
C108967 |
SDZ HDL 376 |
SDZ HDL 376 analog inhibits the reaction [SCARB1 protein results in increased export of Cholesterol, HDL] | decreases reaction|increases export | 17533223
|
C108967 |
SDZ HDL 376 |
SDZ HDL 376 analog inhibits the reaction [SCARB1 protein results in increased uptake of cholesteryl oleyl ether] | decreases reaction|increases uptake | 17533223
|
C108967 |
SDZ HDL 376 |
SDZ HDL 376 analog results in decreased activity of SCARB1 protein | decreases activity | 17533223
|
C108967 |
SDZ HDL 376 |
SDZ HDL 376 inhibits the reaction [SCARB1 protein results in increased export of Cholesterol, HDL] | decreases reaction|increases export | 17533223
|
C108967 |
SDZ HDL 376 |
SDZ HDL 376 inhibits the reaction [SCARB1 protein results in increased uptake of cholesteryl oleyl ether] | decreases reaction|increases uptake | 17533223
|
C108967 |
SDZ HDL 376 |
SDZ HDL 376 results in decreased activity of SCARB1 protein | decreases activity | 17533223
|
D012645 |
Selenomethionine |
Selenomethionine affects the expression of SCARB1 mRNA | affects expression | 17222674
|
C002979 |
selenomethylselenocysteine |
selenomethylselenocysteine results in increased expression of SCARB1 mRNA | increases expression | 18514395
|
D012980 |
Sodium Salicylate |
Sodium Salicylate results in decreased expression of SCARB1 protein | decreases expression | 16816107
|
D012980 |
Sodium Salicylate |
Sodium Salicylate results in increased expression of SCARB1 protein | increases expression | 16816107
|
D018038 |
Sodium Selenite |
Sodium Selenite results in increased expression of SCARB1 mRNA | increases expression | 18514395
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of SCARB1 mRNA | decreases expression | 16443690
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of SCARB1 mRNA | increases expression | 18796159
|
C423915 |
TO-901317 |
TO-901317 results in increased expression of SCARB1 mRNA | increases expression | 16142410
|
D014108 |
Tosylphenylalanyl Chloromethyl Ketone |
Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in decreased expression of SCARB1 mRNA] | decreases expression|decreases reaction | 12010990
|
C540004 |
WAY-362450 |
WAY-362450 results in increased expression of SCARB1 mRNA | increases expression | 19136377
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Diethylhexyl Phthalate |
21.34 | 6734493 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Ethanol |
21.34 | 17676605 18926900 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
21.34 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenytoin |
21.34 | 9677735 9118846 10563481 6195326 3425630 8986270 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
21.34 | 15322242 14514962 11752688 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
8.78 | 18287403 |
MESH:D000138 |
Acidosis |
|
Ethanol |
8.78 | 11192467 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.42 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.65 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
3.71 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
3.71 | 14692618 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
2.55 | 10737359 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
20.69 | 17162532 18056438 19052882 19061943 17620307 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
20.69 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
20.69 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
20.69 | 16835633 |
MESH:D020268 |
Alcohol-Induced Disorders, Nervous System |
|
Ethanol |
4.80 | 15451039 15451040 |
MESH:D000544 |
Alzheimer Disease |
|
27-hydroxycholesterol |
4.86 | 14523054 20157255 |
MESH:D000544 |
Alzheimer Disease |
|
Cholesterol, Dietary |
4.86 | 20157255 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.51 | 11748828 |
MESH:D000853 |
Anophthalmos |
|
Ethanol |
4.32 | 15513904 |
MESH:D001008 |
Anxiety Disorders |
|
Ethanol |
3.60 | 11141031 |
MESH:D001161 |
Arteriosclerosis |
|
Cholesterol, Dietary |
14.34 | 15552841 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
14.34 | 15238619 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
14.34 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Dexamethasone |
10.61 | 17659584 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
10.61 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
Tosylphenylalanyl Chloromethyl Ketone |
10.61 | 18706406 |
MESH:D055963 |
Asthma, Aspirin-Induced |
|
Aspirin |
4.28 | 12372130 20485159 |
MESH:D050197 |
Atherosclerosis |
|
27-hydroxycholesterol |
9.63 | 9059518 11166758 |
MESH:D050197 |
Atherosclerosis |
|
Cholesterol |
9.63 | 16632123 |
MESH:D050197 |
Atherosclerosis |
|
Phenytoin |
9.63 | 15136057 |
MESH:D001289 |
Attention Deficit Disorder with Hyperactivity |
|
Phthalic Acids |
4.01 | 20106747 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
7.26 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
7.26 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.27 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.43 | 15746008 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.41 | 11985600 |
MESH:D002545 |
Brain Ischemia |
|
beta Carotene |
4.59 | 16157235 |
MESH:D001932 |
Brain Neoplasms |
|
Aspirin |
3.98 | 15481559 |
MESH:D001943 |
Breast Neoplasms |
|
alitretinoin |
4.20 | 16344269 |
MESH:D001943 |
Breast Neoplasms |
|
Aspirin |
4.20 | 15161893 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
4.20 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
4.20 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
4.20 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
4.20 | 12948864 19861407 18497071 17261762 17289903 14630087 16675129 17018787 |
MESH:D001943 |
Breast Neoplasms |
|
selenomethylselenocysteine |
4.20 | 18855134 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
4.20 | 20435547 |
MESH:D002056 |
Burns |
|
Ethanol |
4.16 | 16374292 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
3.95 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.40 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
10.02 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
10.02 | 21507988 12907637 12619106 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
10.02 | 19701751 19383236 10672840 20935162 19539802 16540662 19171122 18971187 19052882 19919837 18506893 18494052 18210153 20432363 17055752 16878318 21159647 16681979 20514400 18691550 18393292 16569478 19335982 20084675 17761372 16502159 16779866 18056438 17173139 18978308 17978847 20007298 3084413 20101231 16288022 16830150 3581430 19394651 17138121 16698587 19822196 16328049 17162532 18788625 16935385 17428255 20524982 19208518 10737359 18785209 19107877 18665156 16807293 20512989 20727157 19418558 11831363 19519916 20214788 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
10.02 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Ethanol |
10.02 | 15289165 18788625 15763234 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
10.02 | 17173139 1701930 20935162 6705139 20007298 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.48 | 17123778 |
MESH:D002292 |
Carcinoma, Renal Cell |
marker/mechanism |
|
| 21131975 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
retinol palmitate |
4.21 | 15984520 |
MESH:D006332 |
Cardiomegaly |
|
Ethanol |
5.85 | 19332462 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
5.85 | 16120746 18850075 18670907 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
9.08 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
9.08 | 7505956 21159647 17174075 2727394 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
9.08 | 18566989 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
10.02 | 4080065 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenytoin |
10.02 | 4080065 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
7.90 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
7.90 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
16.18 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
16.18 | 17333356 16105132 15861022 17681005 17110522 16919318 11677210 |
MESH:D002779 |
Cholestasis |
|
Lithocholic Acid |
16.18 | 19965603 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
16.18 | 19176532 |
OMIM:601042 |
CHOREOATHETOSIS/SPASTICITY, EPISODIC |
|
Phenytoin |
5.36 | 11748493 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
4.25 | 15894690 |
MESH:D002971 |
Cleft Lip |
|
Ethanol |
7.00 | 15513904 |
MESH:D002971 |
Cleft Lip |
|
Phenytoin |
7.00 | 2227380 |
MESH:D002972 |
Cleft Palate |
|
Ethanol |
8.61 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Phenytoin |
8.61 | 10789828 6856622 3877104 1687470 6862529 2227380 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
8.61 | 12621046 15340226 15668235 8697196 16354765 |
MESH:D003103 |
Coloboma |
|
Phenytoin |
4.70 | 9212184 |
MESH:D003110 |
Colonic Neoplasms |
|
Aspirin |
3.82 | 12411196 |
MESH:D003110 |
Colonic Neoplasms |
|
Dexamethasone |
3.82 | 15824018 |
MESH:D015179 |
Colorectal Neoplasms |
|
Aspirin |
2.74 | 17047198 |
MESH:D000013 |
Congenital Abnormalities |
|
Phenytoin |
7.96 | 10627286 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
7.96 | 14669216 17141729 |
MESH:D003327 |
Coronary Disease |
|
Fructose |
4.14 | 18504504 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Dexamethasone |
4.90 | 17728286 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Ethanol |
4.90 | 10194807 19302082 15513904 15451039 11198716 15451040 11873399 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Phenytoin |
4.90 | 19952982 8986270 9212184 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
4.90 | 10048152 20055451 15322242 |
MESH:D003456 |
Cryptorchidism |
|
Dibutyl Phthalate |
4.96 | 16037377 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
3.52 | 18551238 |
MESH:D003715 |
Dengue |
|
27-hydroxycholesterol |
5.17 | 19427377 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dexamethasone |
2.94 | 12438553 |
MESH:D003876 |
Dermatitis, Atopic |
|
Diethylhexyl Phthalate |
6.12 | 16882537 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
6.12 | 18249437 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.35 | 16285004 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Fructose |
4.08 | 18603373 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
6.33 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Fructose |
6.33 | 18603373 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
6.33 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
2.99 | 19279558 |
MESH:D003967 |
Diarrhea |
|
Dexamethasone |
3.23 | 7237001 |
OMIM:607208 |
DRAVET SYNDROME |
|
Phenytoin |
4.89 | 11748493 |
MESH:D003875 |
Drug Eruptions |
|
Phenytoin |
5.00 | 15024534 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
10.10 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
10.10 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Ethanol |
10.10 | 11566570 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
10.10 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
10.10 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.38 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
12.78 | 18367378 |
MESH:D050171 |
Dyslipidemias |
|
Fenofibrate |
12.78 | 16707586 |
MESH:D050171 |
Dyslipidemias |
|
WAY-362450 |
12.78 | 19136377 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
3.54 | 1851702 |
MESH:D004485 |
Eczema |
|
Dexamethasone |
3.98 | 12438553 |
MESH:D004487 |
Edema |
|
Aspirin |
21.22 | 17259670 |
MESH:D004487 |
Edema |
|
Dexamethasone |
21.22 | 19703484 |
MESH:D004487 |
Edema |
|
perfluorooctanoic acid |
21.22 | 12083418 17259670 |
MESH:D004487 |
Edema |
|
pirinixic acid |
21.22 | 12083418 |
MESH:D004487 |
Edema |
|
Sodium Salicylate |
21.22 | 10653021 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
21.22 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.38 | 18230668 15322242 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
27-hydroxycholesterol |
12.88 | 17410599 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
12.88 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Phenytoin |
12.88 | 17654737 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
6.63 | 11473722 19148513 18566989 |
MESH:D016889 |
Endometrial Neoplasms |
|
Fenofibrate |
6.63 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.58 | 10568697 9294722 |
MESH:D019446 |
Endotoxemia |
|
lipopolysaccharide, Escherichia coli 0111 B4 |
5.08 | 12954792 |
MESH:D004816 |
Epidermal Necrolysis, Toxic |
|
Phenytoin |
4.72 | 20235791 |
MESH:D004820 |
Epidermolysis Bullosa |
|
Phenytoin |
5.71 | 6251365 1399206 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
3.61 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
8.62 | 3922381 11558140 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenytoin |
8.62 | 11558140 17116037 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
6.10 | 20417680 |
MESH:D004827 |
Epilepsy |
|
Phenytoin |
6.10 | 20417680 11434505 821787 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.12 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
10.02 | 7750514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenytoin |
10.02 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
9.16 | 3659116 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenytoin |
9.16 | 3659116 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.60 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
Ethanol |
2.61 | 16704527 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.63 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
30.02 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
30.02 | 17967931 18296743 19551842 19004024 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
30.02 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
Ethanol |
30.02 | 18620774 16409862 19236843 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
30.02 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Fructose |
30.02 | 18641190 19196556 18395287 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
30.02 | 20131406 19236843 |
MESH:D005235 |
Fatty Liver, Alcoholic |
|
Ethanol |
5.15 | 17920746 |
MESH:D005310 |
Fetal Alcohol Syndrome |
|
Ethanol |
4.79 | 16946407 10194807 15451040 15513904 |
MESH:D005313 |
Fetal Death |
|
Phenytoin |
9.09 | 10627286 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
9.09 | 11858732 |
MESH:D005334 |
Fever |
|
lipopolysaccharide, Escherichia coli 0111 B4 |
4.76 | 16997862 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
17.14 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
17.14 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Fructose |
17.14 | 18504504 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
17.14 | 20067830 |
MESH:D005756 |
Gastritis |
|
Ethanol |
4.18 | 15046732 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
11.22 | 8708960 |
MESH:D005885 |
Gingival Hyperplasia |
|
Phenytoin |
11.22 | 9029455 |
MESH:D019214 |
Gingival Overgrowth |
|
Phenytoin |
5.71 | 14659971 16390469 |
MESH:D005909 |
Glioblastoma |
|
Aspirin |
3.62 | 12870263 |
MESH:D018149 |
Glucose Intolerance |
|
Fructose |
4.85 | 19165636 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.08 | 10696789 |
MESH:D006261 |
Headache |
|
Aspirin |
4.44 | 15240983 |
MESH:D006258 |
Head and Neck Neoplasms |
|
retinol palmitate |
4.91 | 15984520 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.05 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.21 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
3.91 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.88 | 11000095 |
MESH:D006526 |
Hepatitis C |
marker/mechanism |
|
| 17517063 |
MESH:D006529 |
Hepatomegaly |
|
perfluorooctanoic acid |
16.64 | 3609246 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
16.64 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
16.64 | 18467677 16221962 19772884 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
16.64 | 12621046 15340226 16120746 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Dexamethasone |
2.87 | 7520565 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.51 | 15709030 |
OMIM:610762 |
HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6 |
marker/mechanism |
|
| |
MESH:D015658 |
HIV Infections |
|
beta Carotene |
3.77 | 16960176 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.24 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.53 | 16354765 18606429 8697196 15340226 16959395 |
MESH:D012001 |
Hyperacusis |
|
Aspirin |
5.24 | 15240983 |
MESH:D006930 |
Hyperalgesia |
|
Ethanol |
6.90 | 18783367 |
MESH:D006930 |
Hyperalgesia |
|
perfluorooctanoic acid |
6.90 | 12083418 |
MESH:D006937 |
Hypercholesterolemia |
|
27-hydroxycholesterol |
23.83 | 17873880 |
MESH:D006937 |
Hypercholesterolemia |
|
Cholesterol |
23.83 | 16933029 |
MESH:D006937 |
Hypercholesterolemia |
|
Cholesterol, Dietary |
23.83 | 10876104 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
23.83 | 21332399 |
MESH:D006937 |
Hypercholesterolemia |
|
ezetimibe |
23.83 | 15374793 17076980 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.74 | 20558911 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Phenytoin |
4.24 | 10459572 |
MESH:D006946 |
Hyperinsulinism |
|
Fructose |
4.47 | 18360027 19008412 14757778 18563319 15752949 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
8.00 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
Fructose |
8.00 | 15752949 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
10.61 | 10903974 |
MESH:D006973 |
Hypertension |
|
Dexamethasone |
10.61 | 17042910 |
MESH:D006973 |
Hypertension |
|
Fructose |
10.61 | 14633139 19008412 16843071 14573337 14568997 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
10.61 | 18850075 18670907 |
MESH:D015228 |
Hypertriglyceridemia |
|
Fructose |
4.63 | 19342510 19799862 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.31 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
2.99 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.15 | 17937319 |
MESH:D007249 |
Inflammation |
|
Dexamethasone |
16.27 | 11099482 8960868 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
16.27 | 20412841 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
16.27 | 18785209 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
16.27 | 17296493 |
MESH:D007249 |
Inflammation |
|
perfluorooctanoic acid |
16.27 | 12083418 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
16.27 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
24.47 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
24.47 | 11836018 18457598 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
24.47 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
Fructose |
24.47 | 19008412 18981581 14573337 18057795 19799862 17133782 19342510 18563319 14757778 14633139 19586609 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
24.47 | 16306350 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
24.47 | 14714311 |
MESH:D007569 |
Jaw Abnormalities |
|
Ethanol |
8.61 | 15513904 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
8.61 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
3.92 | 15604871 |
MESH:D017492 |
Keratosis, Seborrheic |
|
alitretinoin |
5.13 | 16144296 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
4.91 | 18776723 10903974 8314463 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
4.91 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
9.97 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
9.97 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
9.97 | 15610895 |
MESH:D007859 |
Learning Disorders |
|
Cholesterol |
8.52 | 17134702 |
MESH:D007859 |
Learning Disorders |
|
Ethanol |
8.52 | 15451040 |
MESH:D007984 |
Leydig Cell Tumor |
|
perfluorooctanoic acid |
4.72 | 8812269 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Ethanol |
3.44 | 17676605 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
13.33 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
13.33 | 18665156 19638242 20032147 18522880 18407596 |
MESH:D008103 |
Liver Cirrhosis |
|
Ethanol |
13.33 | 15289165 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
13.33 | 21047994 |
MESH:D008104 |
Liver Cirrhosis, Alcoholic |
|
Ethanol |
4.59 | 18295389 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dexamethasone |
7.67 | 16718785 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
7.67 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Ethanol |
7.67 | 18166357 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Fenofibrate |
7.67 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
7.67 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
7.67 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
5.77 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
5.77 | 19363144 |
MESH:D008107 |
Liver Diseases |
|
Phenytoin |
5.77 | 14986274 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Ethanol |
4.16 | 17347304 17207112 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
25.77 | 18177683 2125692 15890375 9163691 |
MESH:D008113 |
Liver Neoplasms |
|
Clofibric Acid |
25.77 | 17602206 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylhexyl Phthalate |
25.77 | 11940454 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
25.77 | 18754104 19090486 21047994 19642983 12112319 20118626 20452335 2862719 19073162 10737359 19833225 20492335 21278145 18648771 19812893 19255062 19426721 15885732 18644402 21167192 12771043 20583210 19638242 20501860 20137499 18978307 19690152 19256749 19499222 19294768 19427195 9163691 19850985 20434301 16942905 19996281 19551842 15175105 21071580 19254457 2422723 20101389 18977376 20405173 |
MESH:D008113 |
Liver Neoplasms |
|
Fenofibrate |
25.77 | 18978307 |
MESH:D008113 |
Liver Neoplasms |
|
perfluorooctanoic acid |
25.77 | 14757943 18709148 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
25.77 | 19073162 19482888 19812893 15975961 21047994 8742319 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
25.77 | 20007298 16377806 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
25.77 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
19.09 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
beta Carotene |
19.09 | 17113696 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
19.09 | 18544905 9362446 18093689 19539802 19009564 19004024 3124819 17942915 18775883 21159647 18079962 18282651 19126423 17174075 16842330 17854601 19519916 2563599 18308698 16267830 18253720 18164116 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Fenofibrate |
19.09 | 18253720 18775883 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
19.09 | 17172636 2563599 1399818 18308698 6150874 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
19.09 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
7.51 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
alitretinoin |
7.51 | 16413115 |
MESH:D008175 |
Lung Neoplasms |
|
beta Carotene |
7.51 | 16401635 |
MESH:D008175 |
Lung Neoplasms |
|
Dexamethasone |
7.51 | 15824018 11195469 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
7.51 | 6695378 20970405 21163286 20512841 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
7.51 | 19555203 11884234 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Rifampin |
5.62 | 11422169 |
MESH:D008180 |
Lupus Erythematosus, Systemic |
|
Rifampin |
3.81 | 11422169 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
3.59 | 14737004 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
5.44 | 17203775 11807958 16891317 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
selenomethylselenocysteine |
5.44 | 15318939 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
3.96 | 19453300 |
MESH:D008569 |
Memory Disorders |
|
Ethanol |
3.71 | 15451040 18411066 |
MESH:D008607 |
Mental Retardation |
|
Phenytoin |
3.48 | 9212184 |
MESH:D024821 |
Metabolic Syndrome X |
|
Fructose |
4.40 | 17098227 18497449 19165636 17261469 16815490 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.27 | 16801185 |
MESH:D008881 |
Migraine Disorders |
|
Aspirin |
3.70 | 15240983 |
MESH:D009101 |
Multiple Myeloma |
|
Dexamethasone |
3.14 | 15867202 16118317 15744524 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.01 | 16239165 |
MESH:D009164 |
Mycobacterium Infections |
|
Rifampin |
5.03 | 18474467 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Dexamethasone |
3.24 | 9809623 |
MESH:D009203 |
Myocardial Infarction |
|
Aspirin |
5.15 | 12692751 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.15 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.61 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
6.94 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
6.94 | 16411023 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
10.80 | 17484760 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenytoin |
10.80 | 17484760 |
MESH:D009224 |
Myotonia Congenita |
|
Phenytoin |
4.90 | 1896199 |
MESH:D009325 |
Nausea |
|
Aspirin |
4.70 | 15240983 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
3.35 | 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.35 | 3581430 9029167 |
MESH:D009369 |
Neoplasms |
|
alitretinoin |
6.93 | 16946489 |
MESH:D009369 |
Neoplasms |
|
beta Carotene |
6.93 | 17051425 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
6.93 | 17405874 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.23 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
3.92 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
2.86 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
13.57 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
13.57 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
13.57 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Phenytoin |
3.79 | 9118846 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
2.93 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.60 | 20387270 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
Cholesterol |
10.69 | 9802331 20557099 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
perfluorooctanoic acid |
10.69 | 9802331 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
6.62 | 20132043 21332399 19632207 17217161 20518802 18674790 11836018 18457598 16723640 |
MESH:D009765 |
Obesity |
|
Fructose |
6.62 | 18585860 17707055 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
6.62 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
2.99 | 16049721 12819281 |
MESH:D010003 |
Osteoarthritis |
|
Aspirin |
3.74 | 7009135 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
10.38 | 17016548 |
MESH:D010018 |
Osteomalacia |
|
Phenytoin |
10.38 | 17016548 |
MESH:D010033 |
Otitis Media |
|
retinol palmitate |
6.36 | 17303254 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.48 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
2.05 | 19401270 |
MESH:D010146 |
Pain |
|
Aspirin |
6.17 | 6995502 6363464 |
MESH:D010146 |
Pain |
|
Phenytoin |
6.17 | 15215642 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
7.46 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Ethanol |
7.46 | 12384795 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
7.46 | 16965848 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.22 | 11578682 |
MESH:D010300 |
Parkinson Disease |
|
Cholesterol, Dietary |
3.97 | 19014385 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.73 | 12520081 |
MESH:D010438 |
Peptic Ulcer Hemorrhage |
|
Aspirin |
5.03 | 11156591 |
MESH:D020795 |
Photophobia |
|
Aspirin |
5.24 | 15240983 |
MESH:D017689 |
Polydactyly |
|
Phenytoin |
4.61 | 9212184 |
MESH:D017499 |
Porokeratosis |
|
alitretinoin |
5.48 | 16144296 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.08 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
12.79 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
12.79 | 2563599 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
12.79 | 2563599 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Dexamethasone |
3.25 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
13.39 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
perfluorooctanoic acid |
13.39 | 17132714 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
13.39 | 11399792 11118676 11896295 11222880 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
9.04 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
9.04 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.79 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.79 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
2.79 | 18760546 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
2.81 | 16919318 15861022 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
10.83 | 12752131 |
MESH:D019310 |
Pseudolymphoma |
|
Phenytoin |
10.83 | 12752131 1419762 8603615 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.03 | 16882103 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.28 | 10548101 |
MESH:D011649 |
Pulmonary Alveolar Proteinosis |
|
27-hydroxycholesterol |
5.87 | 15466366 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.12 | 19058328 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Dexamethasone |
3.55 | 18379247 11700416 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.35 | 18990726 |
MESH:D012220 |
Rhinitis |
|
Aspirin |
3.94 | 12372130 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
11.24 | 18551238 |
MESH:D012640 |
Seizures |
|
Ethanol |
11.24 | 9754883 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
11.24 | 11442880 3137016 4039156 16876388 |
MESH:D012640 |
Seizures |
|
Phenytoin |
11.24 | 3691417 19919933 16876388 15946322 9844417 3137016 11044598 10029267 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.31 | 6407741 |
MESH:D012851 |
Sinus Thrombosis, Intracranial |
|
Aspirin |
4.77 | 12269725 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
1.79 | 16192470 |
MESH:D019082 |
Smith-Lemli-Opitz Syndrome |
|
27-hydroxycholesterol |
5.52 | 11254748 |
OMIM:270800 |
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE |
|
27-hydroxycholesterol |
5.86 | 19812052 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.42 | 16709447 |
MESH:D013262 |
Stevens-Johnson Syndrome |
|
Phenytoin |
4.66 | 20235791 |
MESH:D013272 |
Stomach Diseases |
|
beta Carotene |
8.93 | 17638125 |
MESH:D013272 |
Stomach Diseases |
|
Dexamethasone |
8.93 | 15472012 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
2.45 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Ethanol |
2.45 | 18456281 |
MESH:D013276 |
Stomach Ulcer |
|
beta Carotene |
9.69 | 12500499 |
MESH:D013276 |
Stomach Ulcer |
|
Dexamethasone |
9.69 | 15138204 |
MESH:D013276 |
Stomach Ulcer |
|
Ethanol |
9.69 | 17918041 16755016 11906479 17189318 9211565 9562338 |
MESH:D020521 |
Stroke |
|
Aspirin |
3.97 | 16403987 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.48 | 16045194 16684133 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Ethanol |
3.81 | 9754883 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.15 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Aspirin |
7.77 | 17672075 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
7.77 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.38 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
5.89 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
5.89 | 1399818 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.17 | 19048282 |
MESH:D014376 |
Tuberculosis |
|
Rifampin |
4.44 | 18397238 15236969 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
2.08 | 16049721 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
3.81 | 10091137 |
MESH:D014581 |
Urticaria |
|
Aspirin |
3.98 | 20485159 10982225 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.49 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
2.82 | 14692618 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
10.05 | 1336536 |
MESH:D014605 |
Uveitis |
|
Dexamethasone |
10.05 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.08 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.08 | 14671159 15869587 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.73 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.31 | 16723640 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
3.92 | 17120751 |